We are studying whether a new formulation of Pembrolizumab is similar to existing treatments for patients with completely removed stage IIB, IIC, and III melanoma. This research aims to ensure effective adjuvant therapy options for these patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Stage IIB, IIC, and III Melanoma refers to advanced stages of skin cancer where the melanoma has been completely removed (resected) but may have spread to nearby lymph nodes or tissues. Early detection and treatment are crucial for better outcomes.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
